“…Of these, bacteria stand out as particularly promising vehicles, especially for applications in human health . Using bacteria, significant research has been directed toward engineering probiotics to provide health benefits such as mitigating genetic disorders, controlling Crohn’s disease, inhibiting pathogen growth, and reducing the risk of colorectal cancer. − Escherichia coli Nissle 1917 and lactic acid bacteria are frequently chosen strains for these purposes. ,,, However, the Bacteroides genus, a commensal bacteria group, is gaining interest due to its superior colonization stability, making it an emerging candidate for live biotherapeutics. , Among them, Bacteroides thetaiotaomicron, a prevalent species in the human gut microbiome, demonstrates a unique ability to digest a diverse range of polysaccharides, including starch and pectin from various sources. − This capability is attributed to enzymes responsible for 88 polysaccharide utilization loci . Additionally, B.…”